Cytomegalovirus Retinitis Market Trends, Size, Growth and Demand, 2023
United States, 8 December 2017
-- One of the major trends noticed in the cytomegalovirus retinitis market is usage of off-label drugs for the treatment of cytomegalovirus retinitis.
Innovation of products focusing on better efficacy, growing demographics and growing economies in the developing countries, such as China and India, are some of the opportunities for global cytomegalovirus retinitis market.
Cytomegalovirus retinitis is eye disease caused due to retina inflammation of eye. The causative agent of the disease is cytomegalovirus, a herpes virus that affects the photosensitive cells of retina. After affecting the retina, the disease spreads from one eye to another eye, which can lead to blindness, if left untreated. Photophobia, blurred vision, seeing floaters and blind spots are the symptoms of cytomegalovirus retinitis. Cytomegalovirus retinitis usually affects people with weak immune system, including HIV affected patients. Various forms of cytomegalovirus retinitis medication are solutions, capsules, tablets and implants.
To know more about Cytomegalovirus Retinitis Market: https://www.psmarketresearch.com/market-analysis/cytomegalovirus-retinitis-market
Cytomegalovirus retinitis is an emergency situation because if a black spot in the visual field appears once, the disease cannot be cured due to its permanent in nature. If posterior pole is involved, it leads to approximately one half of incident visual acuity loss. Ophthalmology is the branch of medical science that deals with the study and management of physiology, anatomy and the diseases related to the human eye. The vision loss and incidence of eye disorders are becoming a major public health issues which include various eye diseases such as glaucoma, age-related macular degeneration, cataract, diabetic macular edema, retinal detachment, ocular hypertension, bulging eyes, refractive errors and uveitis. Active cytomegalovirus retinitis is generally treated by uveitis or ocular immunology specialist. Fomivirsen was the first antisense drug approved by the U.S. Food and Drug Administration (FDA) as an intraocular injection for curing cytomegalovirus retinitis. As the virus creates a worse effect to vision, it is generally treated by a vitreoretinal surgeon with the help of antivirals, such as ganciclovir or foscarnet, which can be taken orally or directly into the eye.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/cytomegalovirus-retinitis-market/report-sample
Some of the major competitors of global cytomegalovirus retinitis market are, Shire Plc, F. Hoffmann-La Roche AG, Hospira Inc., Chimerix Inc., Gilead Sciences Inc., pSivida, Auritec Pharmaceuticals Inc., Sanofi S.A., and Isis Pharmaceuticals Inc.
# # #
Submitted by Jacob, P&S Market Research on Friday, 8 December 2017 at 6:18 AM
Category: Health Care & Medical
Brought to you by Scoopasia [http://scoopasia.com]